CABENVUA and VOCABRIA approved for HIV infection
WEBJan 27, 2021 · Cabenuva and Vocabria are the first FDA-approved injectable, complete regimen for HIV-1 infected adults that is administered once a month. Learn about the dosing, administration, efficacy,...
FDA Approves New HIV Drug for Adults with Limited Treatment …
WEBJan 4, 2023 · Sunlenca (lenacapavir) is a new type of antiretroviral medication for HIV-1 patients who have resistance, intolerance, or safety issues with other treatments. It is the first capsid inhibitor approved by the FDA and is given as oral tablets and subcutaneous injections every six months.
Twice-yearly shot proves successful at preventing HIV infection ... - CNN
WEBJul 24, 2024 · The twice-yearly injection of the drug lenacapavir can provide total protection against HIV infections, demonstrating 100% efficacy in Phase 3 trial data released by drugmaker Gilead and...
Islatravir plus lenacapavir could be the first once-weekly oral HIV ...
WEBMar 6, 2024 · A phase II study shows that switching to weekly islatravir and lenacapavir pills can keep HIV suppressed as well as daily Biktarvy. The combination is safe, well-tolerated and has the potential to become the first weekly oral complete regimen for …
The FDA has approved a new drug in the fight against AIDS
WEBDec 23, 2021 · The Food and Drug Administration has approved the first injectable medication for HIV prevention. Health advocates say it could be a game changer in protecting people against AIDS
New HIV drug can only offer hope of ending AIDS if all have …
WEBJul 10, 2024 · Lenacapavir is an injectable long-acting medicine that showed overwhelming efficacy for preventing HIV infections compared to oral PrEP. UNAIDS urges Gilead to ensure equitable global access to this game-changing medicine through generic production and voluntary licensing agreements.
FDA Approves New HIV Treatment for Patients With Limited …
WEBRukobia (fostemsavir) is a new type of antiretroviral medication for adults living with HIV who have limited treatment options. It was approved by the FDA in July 2020 based on a clinical trial...
FDA Approves First Extended-Release, Injectable Drug Regimen …
WEBJan 21, 2021 · Cabenuva is a once-monthly injection that can replace a current antiretroviral regimen for adults living with HIV. The FDA also approved Vocabria, a tablet to be taken before switching to...
FDA Approves First Extended-Release, Injectable Drug Regimen ... - HIV…
WEBJan 22, 2021 · Cabenuva (cabotegravir and rilpivirine) is a once-monthly injection that can replace daily pills for HIV-infected adults who are virologically suppressed. Learn about the safety, efficacy, and eligibility of this new treatment option …
Expert Panel Recommends New Drugs for HIV Prevention - The New York Times
WEBAug. 22, 2023. An influential expert panel has given its highest recommendation to an expanded menu of H.I.V. prevention strategies for adults and adolescents, a move that will require...
Skip to content